Antithymocyte globulin for the treatment of patients with 'low risk' myelodysplastic syndromes.

S B Killick, J C Marsh, J D Cavenagh, A Mijovic, G Mufti, E C Gordon-Smith, D T Bowen

    Research output: Contribution to journalMeeting abstract

    Original languageEnglish
    Pages (from-to)306A - 307A
    JournalBlood
    Volume94
    Issue number10
    Publication statusPublished - 1999

    Cite this